Lawrence Steinman, a director at Pasithea Therapeutics Corp. ($KTTA), made one open market purchase of common shares in the last year, totaling about $100,000. His most recent buy occurred on November 28, 2025. This ranks him 2,265th among nearly 5,000 individual insiders by purchase value, below the average of $1.5 million across about three transactions per insider. Steinman reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 28, 2025 | Pasithea Therapeutics Corp. | $KTTA | STEINMAN LAWRENCE | Director | P | Common Stock | 133333 | $0.75 | 199,691.0000 | 7,443,577 | 200.93% | 1.79% |
| Oct. 24, 2025 | Pasithea Therapeutics Corp. | $KTTA | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 242913 | $0.00 | 242,913.0000 | 7,443,577 | 9999.99% | 3.26% |
| June 17, 2025 | FORUM MARKETS Inc | $FRMM | STEINMAN LAWRENCE | Director | A | Non-Qualified Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 3,539,331 | 9999.99% | 3.11% |
| June 17, 2025 | FORUM MARKETS Inc | $FRMM | STEINMAN LAWRENCE | Director | A | Common Stock | 44959 | $0.00 | 112,493.0000 | 3,539,331 | 66.57% | 1.27% |
| June 17, 2025 | FORUM MARKETS Inc | $FRMM | STEINMAN LAWRENCE | Director | A | Non-Qualified Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 3,539,331 | 9999.99% | 3.11% |
| June 17, 2025 | FORUM MARKETS Inc | $FRMM | STEINMAN LAWRENCE | Director | A | Common Stock | 48198 | $0.00 | 115,732.0000 | 3,539,331 | 71.37% | 1.36% |
| June 18, 2025 | BioAtla, Inc. | $BCAB | STEINMAN LAWRENCE | Not found | A | Common Stock | 23500 | $0.00 | 78,459.0000 | 58,099,164 | 42.76% | 0.04% |
| Feb. 20, 2025 | FORUM MARKETS Inc | $FRMM | STEINMAN LAWRENCE | Director | A | Common Stock | 65000 | $0.00 | 67,534.0000 | 915,374 | 2565.11% | 7.10% |
| June 13, 2024 | BioAtla, Inc. | $BCAB | STEINMAN LAWRENCE | Not found | A | Common Stock | 16500 | $0.00 | 54,959.0000 | 48,077,599 | 42.90% | 0.03% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | STEINMAN LAWRENCE | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 1,226,600 | 9999.99% | 0.61% |
| Dec. 19, 2023 | BioAtla, Inc. | $BCAB | STEINMAN LAWRENCE | Director | P | Common Stock | 20000 | $2.05 | 38,459.0000 | 0 | 108.35% | 0.00% |
| June 14, 2023 | BioAtla, Inc. | $BCAB | STEINMAN LAWRENCE | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | Pasithea Therapeutics Corp. | $KTTA | STEINMAN LAWRENCE | Director | P | Common Stock | 30000 | $0.43 | 1,327,174.0000 | 1,303,652 | 2.31% | 2.30% |